玻璃体腔注射抗血管内皮生长因子治疗的年龄相关性黄斑变性患者玻璃体超声表现
回顾性分析41例年龄相关性黄斑变性眼与41只对照眼的玻璃体超声表现,评估重复玻璃体腔注射抗血管内皮生长因子的影响。结果显示治疗眼玻璃体高回声增高(P < 0.001),玻璃体反射率范围随注射次数增加而增大(P = 0.041,R = 0.214),但与抗血管内皮生长因子类型及距末次注射时间无关。
要点
- 治疗眼玻璃体高回声较对照眼增高(P < 0.001)。
- 玻璃体反射率范围随注射次数增加而增大(P = 0.041,R = 0.214)。
- 抗血管内皮生长因子类型和距末次注射时间与超声表现无显著关联(P > 0.05)。
核心结论
- 初步结果表明玻璃体凝胶的超声反射率随注射次数增加而成比例增高。
研究设计与样本
- 回顾性收集41例年龄相关性黄斑变性患者(41只治疗眼)及41只对照眼的数据,记录年龄、性别、注射次数和抗血管内皮生长因子类型(雷珠单抗、阿柏西普)。
- 采用10-MHz后极部探头在开睑、表面麻醉下以卡波姆为超声凝胶对所有眼象限行地形图、定量和动态超声检查并评估玻璃体反射率。
主要发现
- 患者平均年龄79岁(范围:59-94岁),平均玻璃体腔注射抗血管内皮生长因子5次(范围:1-13次)。
- 部分或完全玻璃体后脱离的发生率在超声上未见显著差异。
- 治疗眼玻璃体高回声增高(P < 0.001),玻璃体反射率范围随注射次数增加而增大(P = 0.041,R = 0.214)。
- 抗血管内皮生长因子类型及距末次玻璃体腔注射时间与超声表现无显著关联(P > 0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文称这些结果为初步结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We aimed to assess the relationship of repeated intravitreal injection of anti-vascular endothelial growth factor, the main treatment for exudative age-related macular degeneration, with changes in vitreous ultrasonographic findings in patients with age-related macular degeneration. METHODS: We retrospectively collected data from 41 patients (41 age-related macular degeneration eyes, 41 control eyes) on age, sex, number of injections, and type of anti-vascular endothelial growth factor (ranibizumab, aflibercept). Ocular ultrasonography was performed with open eyelids, under topical anesthesia, and using carbomers as ultrasonographic gel. Topographic, quantitative, and kinetic ultrasonography was performed in all eye quadrants using a 10-MHz posterior pole probe, and vitreous reflectivity was assessed. RESULTS: The mean age of patients was 79 (range: 59-94) years, with a mean of five intravitreal anti-vascular endothelial growth factor injections (range: 1-13). No significant ultrasonographic differences were found relative to the incidence of partial or complete posterior vitreous detachment. Vitreous hyperechogenicity increased in the treated eye (P < 0.001), and the vitreous reflectivity range increased with the number of injections (P = 0.041, R = 0.214). However, the type of anti-vascular endothelial growth factor used and the time elapsed since the last intravitreal injection was not significant (P > 0.05). CONCLUSION: These preliminary results indicate a proportional increase in ultrasonographic reflectivity of vitreous gel with the number of injections.
引用
- Mato-Gondelle T, Bande MF, Paniagua L, et al. ULTRASONOGRAPHIC FINDINGS IN THE VITREOUS OF PATIENTS WITH AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS. Retina. 2018. PMID: 28820850. doi:10.1097/IAE.0000000000001819
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。